We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events (ADANCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01924325
Recruitment Status : Unknown
Verified August 2013 by Xijing Hospital.
Recruitment status was:  Not yet recruiting
First Posted : August 16, 2013
Last Update Posted : August 16, 2013
Information provided by (Responsible Party):
Xijing Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2015
  Estimated Study Completion Date : July 2016